Latest PILA PHARMA News & Updates

See the latest news and media coverage for PILA PHARMA. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
PILA PHARMA

Clinical-stage biotech developing TRPV1 antagonists

pilapharma.com
Headquarters
Malmö, Sweden
Founded year
2014
Company type
Public company
Number of employees
5–10

Last updated

Latest news about PILA PHARMA

In short: Pila Pharma secured funding through warrant exercises and rights issues while advancing its clinical pipeline for obesity and erythromelalgia.

Company announcements

PILA PHARMA

Pila Pharma publishes its 2025 annual report

The report highlights pipeline expansion into obesity, oversubscribed rights issue, preclinical studies with low exposure, and plans for clinical trials in obesity, diabetes, and erythromelalgia.

PILA PHARMA

Pila Pharma calls for annual general meeting

The annual general meeting is held on 19 May 2026 in Malmö with proposals on board election, fees, articles of association amendment and share issue authorisation.

PILA PHARMA

Pila Pharma announces low exposure of XEN-D0501

Analyses show systemic exposure in obese rats was very low, preventing conclusions on bodyweight effects. The company will proceed with clinical trials using its tablet formulation.

PILA PHARMA

Pila Pharma postpones annual report and AGM

The 2025 annual report will be published by 21 April 2026. The AGM is rescheduled to 19 May 2026 at 15:00.

Unlock all announcements with a

Media coverage

Investing.com

Pila Pharma AB (PILA) Earnings Dates & Reports

On this page, you can find detailed information about the financial performance of Pila Pharma AB, including the latest Pila Pharma AB earnings report and...

Unlock all articles with a

Never miss news about PILA PHARMA

Track PILA PHARMA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.